87 related articles for article (PubMed ID: 26575121)
21. MiR-196a Regulates High Glucose-Induced Mesangial Cell Hypertrophy by Targeting p27kip1.
Wang X; Shen E; Wang Y; Jiang Z; Gui D; Cheng D; Chen T; Wang N
J Lab Autom; 2015 Aug; 20(4):491-9. PubMed ID: 25657172
[TBL] [Abstract][Full Text] [Related]
22. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
[TBL] [Abstract][Full Text] [Related]
23. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
24. A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II.
Li L; Li G; Yu C; Shen Z; Xu C; Feng Z; Zhang X; Li Y
Liver Int; 2015 Apr; 35(4):1124-32. PubMed ID: 24351048
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy.
Zhang Z; Luo X; Ding S; Chen J; Chen T; Chen X; Zha H; Yao L; He X; Peng H
FEBS Lett; 2012 Jan; 586(1):20-6. PubMed ID: 21827757
[TBL] [Abstract][Full Text] [Related]
26. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
[TBL] [Abstract][Full Text] [Related]
27. MiR-204/miR-211 downregulation contributes to candidemia-induced kidney injuries via derepression of Hmx1 expression.
Li XY; Zhang K; Jiang ZY; Cai LH
Life Sci; 2014 May; 102(2):139-44. PubMed ID: 24641951
[TBL] [Abstract][Full Text] [Related]
28. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.
Fiorentino L; Cavalera M; Mavilio M; Conserva F; Menghini R; Gesualdo L; Federici M
Acta Diabetol; 2013 Dec; 50(6):965-9. PubMed ID: 23797704
[TBL] [Abstract][Full Text] [Related]
29. miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7.
Chen G; Cao S; Liu F; Liu Y
Biochem J; 2015 Nov; 471(3):357-67. PubMed ID: 26303523
[TBL] [Abstract][Full Text] [Related]
30. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
31. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2.
Zuo B; Zhu J; Li J; Wang C; Zhao X; Cai G; Li Z; Peng J; Wang P; Shen C; Huang Y; Xu J; Zhang X; Chen X
J Bone Miner Res; 2015 Feb; 30(2):330-45. PubMed ID: 25195535
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
33. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
34. MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats.
Li D; Lu Z; Jia J; Zheng Z; Lin S
Kidney Blood Press Res; 2013; 37(4-5):422-31. PubMed ID: 24247359
[TBL] [Abstract][Full Text] [Related]
35. [Effects of tripterygium wilfordii polyglucoside on expression of Activin A and influence of transdifferentiation in renal tubulointerstitium of rats with diabetic nephropathy].
Zhao C; Yu W; Ren X; Zhang W; Li H
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1427-32. PubMed ID: 25142998
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human.
Gutiérrez-Escolano A; Santacruz-Vázquez E; Gómez-Pérez F
Ren Fail; 2015; 37(9):1498-506. PubMed ID: 26337190
[TBL] [Abstract][Full Text] [Related]
37. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
Li Y; Wang H; Li J; Yue W
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
[TBL] [Abstract][Full Text] [Related]
38. [Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic nephropathy rat kidney].
Yang Q; Han B; Xie RJ; Cheng ML
Sheng Li Xue Bao; 2007 Apr; 59(2):190-6. PubMed ID: 17437042
[TBL] [Abstract][Full Text] [Related]
39. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
[TBL] [Abstract][Full Text] [Related]
40. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
Food Chem Toxicol; 2014 Jan; 63():111-8. PubMed ID: 24211521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
